• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Roger G Pertwee, Allyn C. Howlett, +9 authors Ruth Alexandra Ross
  • Medicine, Biology
  • Pharmacological Reviews
  • 2010 (First Publication: 1 December 2010)
  • There are at least two types of cannabinoid receptors (CB1 and CB2). Ligands activating these G protein-coupled receptors (GPCRs) include the phytocannabinoid Δ9-tetrahydrocannabinol, numerousExpand
  • Tiziana Bisogno, Lumír Ondřej Hanuš, +7 authors Vincenzo Di Marzo
  • Medicine, Chemistry
  • British journal of pharmacology
  • 2001 (First Publication: 1 October 2001)
  • 1. (-)-Cannabidiol (CBD) is a non-psychotropic component of Cannabis with possible therapeutic use as an anti-inflammatory drug. Little is known on the possible molecular targets of this compound. WeExpand
  • Susan M. Huang, Tiziana Bisogno, +12 authors Vincenzo Di Marzo
  • Medicine, Chemistry
  • Proceedings of the National Academy of Sciences…
  • 2002 (First Publication: 11 June 2002)
  • The vanilloid receptor VR1 is a nonselective cation channel that is most abundant in peripheral sensory fibers but also is found in several brain nuclei. VR1 is gated by protons, heat, and theExpand
  • Tim C. Kirkham, Claire Michelle Williams, Filomena Fezza, Vincenzo Di Marzo
  • Chemistry, Biology, Medicine
  • British journal of pharmacology
  • 2002 (First Publication: 1 June 2002)
  • Endocannabinoids are implicated in appetite and body weight regulation. In rodents, anandamide stimulates eating by actions at central CB1 receptors, and hypothalamic endocannabinoids may be underExpand
  • Isabel Matias, Marie-Paule Gonthier, +12 authors Vincenzo Di Marzo
  • Medicine
  • The Journal of clinical endocrinology and…
  • 2006 (First Publication: 1 August 2006)
  • CONTEXT Cannabinoid CB(1) receptor blockade decreases weight and hyperinsulinemia in obese animals and humans in a way greatly independent from food intake. OBJECTIVE The objective of this studyExpand